Cargando…
Human cancer-associated fibroblasts enhance glutathione levels and antagonize drug-induced prostate cancer cell death
Drug resistance is a major problem in cancer therapy. A growing body of evidence demonstrates that the tumor microenvironment, including cancer-associated fibroblasts (CAFs), can modulate drug sensitivity in tumor cells. We examined the effect of primary human CAFs on p53 induction and cell viabilit...
Autores principales: | Cheteh, Emarndeena H, Augsten, Martin, Rundqvist, Helene, Bianchi, Julie, Sarne, Victoria, Egevad, Lars, Bykov, Vladimir JN, Östman, Arne, Wiman, Klas G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520886/ https://www.ncbi.nlm.nih.gov/pubmed/28569790 http://dx.doi.org/10.1038/cddis.2017.225 |
Ejemplares similares
-
Interleukin-6 derived from cancer-associated fibroblasts attenuates the p53 response to doxorubicin in prostate cancer cells
por: Cheteh, Emarndeena H., et al.
Publicado: (2020) -
Fibroblasts—a key host cell type in tumor initiation, progression, and metastasis
por: Strell, Carina, et al.
Publicado: (2012) -
Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2021) -
Correction: Mutant p53-reactivating compound APR-246 synergizes with asparaginase in inducing growth suppression in acute lymphoblastic leukemia cells
por: Ceder, Sophia, et al.
Publicado: (2022) -
A thiol‐bound drug reservoir enhances APR‐246‐induced mutant p53 tumor cell death
por: Ceder, Sophia, et al.
Publicado: (2020)